Cantitate/Preț
Produs
Total produse
Vezi coșul
Nanomedicine for Inflammatory Diseases de Lara Scheherazade Milane

Nanomedicine for Inflammatory Diseases

Editat de Lara Scheherazade Milane, Mansoor M. Amiji
en Limba Engleză Paperback – 30 mar 2021
Nanomedicine for Inflammatory Diseases is a cutting-edge resource for clinicians and scientists alike, working at the intersection of development and clinical therapeutics. This text is ideal for graduate level courses in nanomedicine, translational medicine, or inflammatory disease. This book is a progressive hallmark in translational medicine as it unites clinicians treating inflammatory disease with scientists developing experimental nanomedicine therapeutics. The commonality is made through a translational nanomedicine expert – bridging the gap between the laboratory benchtop and the clinical bedside.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 32009 lei  6-8 săpt.
  CRC Press – 30 mar 2021 32009 lei  6-8 săpt.
Hardback (1) 104546 lei  6-8 săpt.
  CRC Press – 18 iul 2017 104546 lei  6-8 săpt.

Preț: 32009 lei

Preț vechi: 36141 lei
-11% Nou

Puncte Express: 480
Preț estimativ în valută:
6125€ • 6468$ • 5097£

Carte tipărită la comandă

Livrare economică 13-27 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367657833
ISBN-10: 036765783X
Pagini: 372
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.91 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Cuprins

Part I • Introduction: Introduction


to Inflammatory Disease,


Nanomedicine, and


Translational Nanomedicine


1 • FUNDAMENTALS OF IMMUNOLOGY


AND INFLAMMATION




2 • PRINCIPLES OF NANOMEDICINE




3 • NANOTOXICITY




4 • TRANSLATIONAL NANOMEDICINE




Part II • Introduction: Primary


Inflammatory Disease


5.1 • BIOLOGY AND CLINICAL TREATMENT


OF INFLAMMATORY BOWEL DISEASE




5.2 • NANOTHERAPEUTICS FOR


INFLAMMATORY BOWEL DISEASE




5.3 • BRIDGING THE GAP BETWEEN


THE BENCH AND THE CLINIC:


INFLAMMATORY BOWEL DISEASE




6.1 • THE BIOLOGY AND CLINICAL


TREATMENT OF MULTIPLE SCLEROSIS




6.2 • NANOTHERAPEUTICS FOR MULTIPLE


SCLEROSIS




6.3 • BRIDGING THE GAP BETWEEN THE


BENCH AND THE CLINIC




7.1 • THE BIOLOGY AND CLINICAL


TREATMENT OF ASTHMA




7.2 • NANOTHERAPEUTICS FOR ASTHMA




7.3 • BRIDGING THE GAP BETWEEN THE


BENCH AND THE CLINIC: ASTHMA




Part III • Introduction:


The Emerging Role


of Inflammation


in Common Diseases


8 • NEURODEGENERATIVE DISEASE




9 • CANCER




10 • DIABETES




11 • CONCLUDING REMARKS

Notă biografică

Dr. Lara Scheherazade Milane recently joined Burrell College of Osteopathic Medicine (Las Cruces, New Mexico) as founding faculty in the Biomedical Sciences Department and is the Director of Online Programing. Dr. Milane received her training as an NCI/NSF Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane has a PhD in Pharmaceutical Science with specializations in Nanomedicine and Drug Delivery Systems (Northeastern University, Boston, MA). She also received her MS in Biology and BS in Neuroscience from Northeastern University.


Dr. Milane’s research interests are in cancer biology, mitochondrial medicine, and translational nanomedicine. Dr. Milane is interested in developing a library of clinically translatable targeted nanomedicine therapies for cancer treatment. She teaches in the medical program and in the post-baccalaureate program. Dr. Milane is an advocate for women in the sciences and is a pioneer for outreach. Dr. Milane has 18 peer reviewed journal publications, 3 book chapters, and 3 white papers.


Dr. Mansoor Amiji is currently the University Distinguished Professor in the Department of Pharmaceutical Sciences and Co-Director of Northeastern University Nanomedicine Education and Research Consortium (NERC) at Northeastern University in Boston, MA. NERC oversees a doctoral training program in Nanomedicine Science and Technology that was co-funded by the National Institutes of Health (NIH) and the National Science Foundation (NSF). Dr. Amiji received his BS degree in pharmacy from Northeastern University in 1988 and a PhD in pharmaceutical sciences from Purdue University in 1992.




His research is focused on development of biocompatible materials from natural and synthetic polymers, target-specific drug and gene delivery systems for cancer and infectious diseases, and nanotechnology applications for medical diagnosis, imaging, and therapy. His research has received over $18 million in sustained funding from the NIH, NSF, private foundations, and the pharmaceutical/biotech industries.




Dr. Amiji teaches in the professional pharmacy program and in the graduate programs of Pharmaceutical Science, Biotechnology, and Nanomedicine. He has published six books and over 200 book chapters, peer-reviewed articles, and conference proceedings. He has received a number of honors and awards including the Nano Science and Technology Institute’s Award for Outstanding Contributions towards the Advancement of Nanotechnology, Microtechnology, and Biotechnology, American Association of Pharmaceutical Scientists (AAPS) Meritorious Manuscript Award, Controlled Release Society’s (CRS) Nagai Award, and the AAPS and CRS Fellowships.

Descriere

Uniting the expertise of leading researchers dealing with inflammatory disease and high caliber nanomedicine scientists developing new therapies for treating these diseases, this book bridges the gap between the laboratory bench top and the clinical bedside. A good resource for biomedical researchers, clinicians, and professors of graduate cours